← Every company
Cogent Biosciences Inc SEC Filings
What Cogent Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
COGT overview →Filings on file
115
since Mar 2, 2018
Warning signs
1
latest Jan 6, 2020
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jan 6, 2020 | Delisting notice or listing transfer 8-K | Read ↗ |
Source: Cogent Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on COGT
Company overviewEverything on COGT in one place, with the price.Insider tradingWhat COGT's own officers and directors buy and sell.Executive payWhat COGT awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in COGT.Funds holding itWhich funds and ETFs hold COGT, and how big a bet.PatentsWhat COGT is filing at the patent office.